B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cellsin vitro
- 1 January 1993
- journal article
- Published by Wiley in European Journal of Immunology
- Vol. 23 (1), 295-298
- https://doi.org/10.1002/eji.1830230148
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Early signaling defects in human T cells anergized by T cell presentation of autoantigen.The Journal of Experimental Medicine, 1992
- Antibody and B7/BB1-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cells.The Journal of Experimental Medicine, 1992
- CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.The Journal of Experimental Medicine, 1992
- Stimulation of Peripheral Blood T Cells by an Activated T‐Cell Line: a Novel Human Autologous T‐T Lymphocyte ReactionScandinavian Journal of Immunology, 1991
- Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathwayCellular Immunology, 1991
- Role of the CD28 receptor in T-cell activationImmunology Today, 1990
- A Cell Culture Model for T Lymphocyte Clonal AnergyScience, 1990
- Endothelial cells augment T cell interleukin 2 production by a contact-dependent mechanism involving CD2/LFA-3 interaction.The Journal of Experimental Medicine, 1990
- Regulation of Lymphokine Messenger RNA Stability by a Surface-Mediated T Cell Activation PathwayScience, 1989
- Clonal Expansion Versus Functional Clonal Inactivation: A Costimulatory Signalling Pathway Determines the Outcome of T Cell Antigen Receptor OccupancyAnnual Review of Immunology, 1989